Search research articles
Contact Us
Filters
Showing results (1-10 of 196) with videos related to
Page
of 20
Sort By:
Recenti Progressi in Medicina
|
August 20, 2008
[The role of interleukin-6 in rheumatoid arthritis]
Mariangela Manfredi, Maurizio Benucci
Annals of the Rheumatic Diseases
|
February 9, 2018
Additional comment to: 'Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?' by Scherlinger and Schaeverbeke
Fabrizio Cantini, Maurizio Benucci
Annals of the Rheumatic Diseases
|
December 31, 2017
Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?
Fabrizio Cantini, Maurizio Benucci
Journal of Medical Economics
|
August 1, 2019
Non-medical switching: save today and pay tomorrow
Maurizio Benucci, Fabrizio Cantini
Recenti Progressi in Medicina
|
December 25, 2009
[Environmental factors and autoimmunity]
Mariangela Manfredi, Maurizio Benucci
Biologics : Targets & Therapy
|
September 15, 2018
Focus on biosimilar etanercept - bioequivalence and interchangeability
Fabrizio Cantini, Maurizio Benucci
Annals of the Rheumatic Diseases
|
November 30, 2018
Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: possible fallout on non-medical switching
Fabrizio Cantini, Maurizio Benucci
Journal of Medical Economics
|
May 14, 2020
Biomarkers and pharmacoeconomics in rheumatoid arthritis: a good marriage
Maurizio Benucci, Maria Infantino, Mariangela Manfredi
Current Medical Research and Opinion
|
October 2, 2007
Comments on: Effects of clarithromycin in patients with active rheumatoid arthritis
Gianantonio Saviola, Maurizio Benucci, Giuseppe Cirino
Internal and Emergency Medicine
|
February 13, 2008
Cardiac engagement in multicentric reticulohistiocytosis: report of a case with fatal outcome and literature review
Maurizio Benucci, Antonio Sulla, Mariangela Manfredi
Page
of 20
Search research articles
Search
Showing results (1-10 of 196) with videos related to
Sort By:
Page
of 20
Recenti Progressi in Medicina
|
August 20, 2008
[The role of interleukin-6 in rheumatoid arthritis]
Mariangela Manfredi, Maurizio Benucci
Annals of the Rheumatic Diseases
|
February 9, 2018
Additional comment to: 'Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?' by Scherlinger and Schaeverbeke
Fabrizio Cantini, Maurizio Benucci
Annals of the Rheumatic Diseases
|
December 31, 2017
Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?
Fabrizio Cantini, Maurizio Benucci
Journal of Medical Economics
|
August 1, 2019
Non-medical switching: save today and pay tomorrow
Maurizio Benucci, Fabrizio Cantini
Recenti Progressi in Medicina
|
December 25, 2009
[Environmental factors and autoimmunity]
Mariangela Manfredi, Maurizio Benucci
Biologics : Targets & Therapy
|
September 15, 2018
Focus on biosimilar etanercept - bioequivalence and interchangeability
Fabrizio Cantini, Maurizio Benucci
Annals of the Rheumatic Diseases
|
November 30, 2018
Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: possible fallout on non-medical switching
Fabrizio Cantini, Maurizio Benucci
Journal of Medical Economics
|
May 14, 2020
Biomarkers and pharmacoeconomics in rheumatoid arthritis: a good marriage
Maurizio Benucci, Maria Infantino, Mariangela Manfredi
Current Medical Research and Opinion
|
October 2, 2007
Comments on: Effects of clarithromycin in patients with active rheumatoid arthritis
Gianantonio Saviola, Maurizio Benucci, Giuseppe Cirino
Internal and Emergency Medicine
|
February 13, 2008
Cardiac engagement in multicentric reticulohistiocytosis: report of a case with fatal outcome and literature review
Maurizio Benucci, Antonio Sulla, Mariangela Manfredi
Page
of 20